Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer. // European Urology Focus. – URL: https://www.sciencedirect.com/science/article/pii/S2405456926001951?dgcid=rss_sd_all
Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer. European Urology Focus. https://www.sciencedirect.com/science/article/pii/S2405456926001951?dgcid=rss_sd_all
“Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer.” European Urology Focus.
@article{article45413,
title = {Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer},
journal = {European Urology Focus},
url = {https://www.sciencedirect.com/science/article/pii/S2405456926001951?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...